Del. Court Asks France To Compel Bristol-Myers VP's Testimony

Law360, New York (December 10, 2012, 4:03 PM EST) -- A Delaware federal judge on Friday asked the French government for help in deposing a Bristol-Myers Squibb Co. executive believed by Cadence Pharmaceuticals Inc. to have information critical to its pursuit of patent infringement claims over injectable acetaminophen treatment Ofirmev.

In a request to France’s Ministry of Justice, U.S. District Judge Leonard P. Stark sought to compel Jehan-Yves Drouin, vice president of market access at Bristol-Myers, to deliver testimony and produce documents Cadence says are important to its suit and to counterclaims lobbed by Exela Pharma...
To view the full article, register now.